Literature DB >> 22350472

Intraoperative blood transfusion contributes to decreased long-term survival of patients with esophageal cancer.

Yoshihiro Komatsu1, Hajime Orita, Mutsumi Sakurada, Hiroshi Maekawa, Toshitaka Hoppo, Koichi Sato.   

Abstract

BACKGROUND: Several prognostic factors for patients who have undergone esophagectomy owing to esophageal squamous cell carcinoma have been suggested, including intraoperative blood loss. There are few data, however, suggesting such an association with the prognosis following radical esophagectomy.
METHODS: Patients with esophageal squamous cell carcinoma who underwent radical esophagectomy were divided into two groups based on the median value of the intraoperative blood loss (510 g). A multivariate Cox proportional-hazard regression analysis was performed to determine if intraoperative blood loss could be an independent prognostic factor for long-term survival following radical esophagectomy. Kaplan-Meier survival analysis with a log-rank test was performed between the groups.
RESULTS: From April 2005 to May 2009, a total of 37 patients underwent radical esophagectomy for the treatment of esophageal squamous cell carcinoma at the Juntendo Shizuoka Hospital and were assigned either to one of two groups: those with ≥510 g blood loss [bleeding group (BG), n = 19] or of those with <510 g blood loss [less bleeding group (LBG), n = 18]. The distribution of the stage of disease, the number of positive lymph nodes, and the presence of lymphatic and vascular invasion was comparable between the groups, but the Kaplan-Meier survival analysis demonstrated that survival was significantly worse in the BG group than in the LBG group (p = 0.00295). This was supported by the multivariate analysis, which indicated that intraoperative blood loss was independently associated with long-term survival after radical esophagectomy.
CONCLUSIONS: Intraoperative blood loss could be a useful prognostic factor following radical esophagectomy in patients with esophageal squamous cell carcinoma.

Entities:  

Mesh:

Year:  2012        PMID: 22350472     DOI: 10.1007/s00268-012-1433-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  34 in total

1.  Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer.

Authors:  Masashi Takemura; Harushi Osugi; Masayuki Higashino; Nobuyasu Takada; Sigeru Lee; Hiroaki Kinoshita
Journal:  Ann Thorac Cardiovasc Surg       Date:  2005-10       Impact factor: 1.520

2.  A proposal of no-touch isolation technique in pancreatoduodenectomy for periampullary carcinomas.

Authors:  S Kobayashi; T Asano; T Ochiai
Journal:  Hepatogastroenterology       Date:  2001 Mar-Apr

3.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

4.  Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions.

Authors:  J Kaplan; S Sarnaik; J Gitlin; J Lusher
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

5.  Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure.

Authors:  R M Roumen; T Hendriks; J van der Ven-Jongekrijg; G A Nieuwenhuijzen; R W Sauerwein; J W van der Meer; R J Goris
Journal:  Ann Surg       Date:  1993-12       Impact factor: 12.969

6.  The association of perioperative blood transfusion with colorectal cancer recurrence.

Authors:  P I Tartter
Journal:  Ann Surg       Date:  1992-12       Impact factor: 12.969

7.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

8.  Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus.

Authors:  M Tachibana; S Kinugasa; D K Dhar; H Tabara; R Masunaga; T Kotoh; H Kubota; N Nagasue
Journal:  Arch Surg       Date:  1999-01

9.  [Therapeutic strategies for advanced respectable esophageal cancer].

Authors:  Yuko Kitagawa
Journal:  Nihon Geka Gakkai Zasshi       Date:  2008-11

10.  Prognostic analysis of the patients with stage-III esophageal squamous cell carcinoma after radical esophagectomy.

Authors:  Yi Hu; Bin Zheng; Tie-Hua Rong; Jian-Hua Fu; Zhi-Hua Zhu; Hong Yang; Kong-Jia Luo; Yong-Feng Li
Journal:  Chin J Cancer       Date:  2010-02
View more
  17 in total

1.  Intraoperative blood transfusion contributes to decreased long-term survival of patients with esophageal cancer: comments on regression model estimation.

Authors:  Francesco Cavallin; Marco Scarpa; Matteo Cagol; Rita Alfieri; Carlo Castoro
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

2.  Allogenic Blood Transfusion is Associated with Poor Perioperative and Long-Term Outcome in Esophageal Cancer.

Authors:  Matthias Reeh; Tarik Ghadban; Josephine Dedow; Eik Vettorazzi; Faik G Uzunoglu; Michael Nentwich; Stefan Kluge; Jakob R Izbicki; Yogesh K Vashist
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

3.  Necessity for autologous blood storage and transfusion in patients undergoing pancreatoduodenectomy.

Authors:  Yoshito Tomimaru; Kozo Noguchi; Keizo Dono
Journal:  Surg Today       Date:  2016-08-22       Impact factor: 2.549

4.  Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer.

Authors:  Sheraz R Markar; Henner Schmidt; Sonia Kunz; Artur Bodnar; Michal Hubka; Donald E Low
Journal:  J Gastrointest Surg       Date:  2014-04-29       Impact factor: 3.452

5.  Red Cell Transfusion Triggers and Postoperative Outcomes After Major Surgery.

Authors:  Yuhree Kim; Gaya Spolverato; Donald J Lucas; Aslam Ejaz; Li Xu; Doris Wagner; Steven M Frank; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-08-26       Impact factor: 3.452

6.  Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study.

Authors:  Jeffrey M Sutton; David A Kooby; Gregory C Wilson; M Hart Squires; Dennis J Hanseman; Shishir K Maithel; David J Bentrem; Sharon M Weber; Clifford S Cho; Emily R Winslow; Charles R Scoggins; Robert C G Martin; Hong Jin Kim; Justin J Baker; Nipun B Merchant; Alexander A Parikh; Daniel E Abbott; Michael J Edwards; Syed A Ahmad
Journal:  J Gastrointest Surg       Date:  2014-06-19       Impact factor: 3.452

7.  Perioperative Predictive Markers for Recurrence of Esophageal Cancer after Esophagectomy.

Authors:  Yoshinori Fujiwara; Masaharu Higashida; Hisako Kubota; Yuko Okamoto; Shumei Mineta; Shunji Endo; Tomio Ueno
Journal:  Gastrointest Tumors       Date:  2021-03-17

8.  The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy.

Authors:  Joong Sub Lee; Hyung Suk Kim; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Korean J Urol       Date:  2015-03-26

Review 9.  Red blood cell transfusions and the survival in patients with cancer undergoing curative surgery: a systematic review and meta-analysis.

Authors:  Fausto Petrelli; Michele Ghidini; Antonio Ghidini; Giovanni Sgroi; Ivano Vavassori; Daniela Petrò; Mary Cabiddu; Alberto Aiolfi; Gianluca Bonitta; Alberto Zaniboni; Emanuele Rausa
Journal:  Surg Today       Date:  2021-01-03       Impact factor: 2.549

10.  Effect of intraoperative HES 6% 130/0.4 on the need for blood transfusion after major oncologic surgery: a propensity-matched analysis.

Authors:  Fernando Godinho Zampieri; Otavio T Ranzani; Priscila Fernanda Morato; Pedro Paulo Campos; Pedro Caruso
Journal:  Clinics (Sao Paulo)       Date:  2013-04       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.